Affiliate Disclosure: This article contains affiliate links. If you buy through one of them we may earn a commission, at no extra cost to you. We only recommend products we genuinely believe in. As an Amazon Associate I earn from qualifying purchases.
Medical Disclaimer: This content is for informational and educational purposes only and is not medical advice. Always consult a qualified healthcare professional before making health decisions or starting any new treatment.
Prostate cancer screening is back in the spotlight following an updated guideline from the American Cancer Society ( ACS), published in November 2026. Before, the advice focused on men discussing the benefits and risk of screening with their doctors. Now the recommendations are more specific, outlining when men should begin regular prostate-specific antigen (PSA) testing, with earlier screening for those at higher risk.
But what does this mean, and who should consider getting screened?
What is Prostate Cancer Screening?
Prostate cancer screening involves checking for signs of cancer before a person develops symptoms. One of the main methods is a prostate-specific antigen (PSA) test.
A PSA test is a blood test that measures the amount of prostate-specific antigen, a protein produced by the prostate gland. Higher-than-normal levels can sometimes indicate prostate cancer, but they may also be caused by other conditions, such as enlarged prostate or an infection.
You can learn more about how the test works in the NHS guide to PSA testing.
What Are the New Prostate Cancer Screening Recommendations?
The American Cancer Society’s November 2026 update recommends:
- Men at average risk: PSA screening every two years between ages 50 and 69.
- Black men: Annual screening from ages 45 to 69.
- Men with a strong family history of prostate cancer: Screening from age 45, with the frequency depending on their family history.
Keep in mind that If you’re not sure about your family history, ask your relatives about it.
That said, the recommendations also encourage men to discuss the potential benefits and risks of screening with their doctors before taking the tests.
You can read the full American Cancer Society prostate cancer screening recommendations.
Does a High PSA Level Mean You Have Prostate Cancer?
Not necessarily. Screening isn’t perfect and an elevated PSA level does not automatically mean someone has cancer. PSA levels can also rise due to infections, en enlarged prostate, and other non-cancerous conditions.
Screening also has limitations. Some may present produce false-positive results while screening can also slow-growing cancers that may never cause serious health problems. This can lead to unnecessary investigations and treatments.
Do the New Recommendations Apply in the UK?
Not exactly. The American Cancer Society’s recommendations are intended for the US, and screening policies differ between countries.
In the UK, the National Screening Committee does not recommend general population screening for prostate cancer.
However, it recommends PSA testing every two years for certain men aged 45 to 61, who have an inherited BRCA2 gene variant and a strong family history of cancer.
The full recommendation, including its eligibility criteria is available in the UK National Screening Committee’s guidance
The bottom line
Prostate cancer screening can help detect cancer earlier, but it also comes with potential risks and limitations. Men should consider their age, family history and individual risks factors when screening with a doctor. An elevated PSA result is not a cancer diagnosis, and you may need further assessment before making a conclusion.
